Sponsor pipeline

The Affiliated People's Hospital of Ningbo University clinical trial pipeline

Get alerts when The Affiliated People's Hospital of Ningbo University's trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-20

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.

  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

New trial filings, last 30 days

First postedTrialPhaseStatus
2026-10-15 NCT07874737 Mitoxantrone Hydrochloride Liposome Combined With Cladribine And Sotorasib For Relapsed… Phase 2 Not Yet Recruiting
2026-09-30 NCT07848672 Early Prophylactic rhTPO Administration for Thrombocytopenia Associated With EAP… Phase 2/3 Not Yet Recruiting

Active trials by phase

Phase 2
1
Phase 2/3
3
Phase 3
3

Disease areas by active trials

Multiple Myeloma (4) · Acute Myeloid Leukemia (AML) (2) · Leukemia (2) · Non-Hodgkin Lymphoma (2) · DLBCL (1)

Get alerts when The Affiliated People's Hospital of Ningbo University's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free